Published 5 hours ago • loading... • Updated 3 hours ago
Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy
Summary by CNBC
4 Articles
4 Articles
Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy
The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.
Hims & Hers starts selling five peptides manipulated in the U.S. without FDA approval and admits there's still a lot to learn about effectiveness
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center1Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium






